title: Distinctive ERK and p38 signaling in remote and infarcted myocardium during post-MI remodeling in the mouse.
abstract: Global activation of MAP kinases has been reported in both human and experimental heart failure. Chronic remodeling of the surviving ventricular wall after myocardial infarction (MI) involves both myocyte loss and fibrosis; we hypothesized that this cardiomyopathy involves differential shifts in pro- and anti-apoptotic MAP kinase signaling in cardiac myocyte (CM) and non-myocyte. Cardiomyopathy after coronary artery ligation in mice was characterized by echocardiography, ex vivo Langendorff preparation, histologic analysis and measurements of apoptosis. Phosphorylation (activation) of signaling molecules was analyzed by Western blot, ELISA and immunohistochemistry. Post-MI remodeling involved dramatic changes in the phosphorylation of both stress-activated MAP (SAP) kinase p38 as well as ERK, a known mediator of cell survival, but not of SAP kinase JNK or the anti-apoptotic mediator of PI3K, Akt. Phosphorylation of p38 rose early after MI in the infarct, whereas a more gradual rise in the remote myocardium accompanied a rise in apoptosis in that region. In both areas, ERK phosphorylation was lowest early after MI and rose steadily thereafter, though infarct phosphorylation was consistently higher. Immunostaining of p-ERK localized to fibrotic areas populated primarily by non-myocytes, whereas staining of p38 phosphorylation was stronger in areas of progressive CM apoptosis. Relative segregation of CMs and non-myocytes in different regions of the post-MI myocardium revealed signaling patterns that imply cell type-specific changes in pro- and anti-apoptotic MAP kinase signaling. Prevention of myocyte loss and of LV remodeling after MI may therefore require cell type-specific manipulation of p38 and ERK activation.
authors.affiliation: Division of Cardiothoracic Surgery, University of California, San Francisco VA Medical Center, San Francisco, CA, USA.
authors.forename: Che-Chung
authors.initials: CC
authors.lastname: Yeh
authors.forename: Hongzhe
authors.initials: H
authors.lastname: Li
authors.forename: Deepak
authors.initials: D
authors.lastname: Malhotra
authors.forename: Sally
authors.initials: S
authors.lastname: Turcato
authors.forename: Susan
authors.initials: S
authors.lastname: Nicholas
authors.forename: Richard
authors.initials: R
authors.lastname: Tu
authors.forename: Bo-Qing
authors.initials: BQ
authors.lastname: Zhu
authors.forename: John
authors.initials: J
authors.lastname: Cha
authors.forename: Philip M
authors.initials: PM
authors.lastname: Swigart
authors.forename: Bat-Erdene
authors.initials: BE
authors.lastname: Myagmar
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Baker
authors.forename: Paul C
authors.initials: PC
authors.lastname: Simpson
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Mann
mesh_terms: D000818:Animals; D017209:Apoptosis; D015153:Blotting, Western; D009202:Cardiomyopathies / Q000378:metabolism; D002478:Cells, Cultured; D004452:Echocardiography; D004797:Enzyme-Linked Immunosorbent Assay; D020287:In Situ Nick-End Labeling; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009203:Myocardial Infarction / Q000378:metabolism* / Q000503:physiopathology; D009206:Myocardium / Q000378:metabolism*; D032383:Myocytes, Cardiac / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism
chemical_list: D048051:p38 Mitogen-Activated Protein Kinases